BioHealth News Archive
MIMETAS and Roche Enter into a Collaboration to Develop Human Disease Models for Drug Development
LEIDEN, The Netherlands, July 06, 2021 / B3C newswire / -- MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading…
Read MoreBioTalk with Rich Bendis welcomes Howard Carolan, CEO of CoapTech, and Neil Davis, Program Director at University of Maryland Baltimore
Howard Carolan, Co-Founder and CEO of CoapTech, Inc., and Neil Davis, Program Director of the Biomedical Entrepreneurship Graduate Certificate program at the University of…
Read MoreSeven Up-and-Coming COVID-19 Drugs
Thanks to unprecedented development speed and mostly strong safety and efficacy data, vaccines have dominated the response to COVID-19. But ending the pandemic will…
Read MoreKinexum ATTD 2021 report.pdf(Shared)- Adobe Document Cloud
This document has been redacted by Sam Collaudin, Kinexum Business Strategy Consultant, independently from any pharmaceutical and biotech companies It synthesizes selected data presented…
Read MoreMoney Moves: It’s a big investment week for Frederick companies – Technical.ly Baltimore
This week, a pair of Frederick companies raised millions in new investment, offering evidence of the Maryland city’s growing role as one of the…
Read MoreRon Daniels’ tenure as Johns Hopkins University president extended through 2029 | Hub
Johns Hopkins University's board of trustees has voted unanimously to add a new five-year term to the presidential tenure of Ron Daniels, an extension…
Read MoreVigene Biosciences closes deal to be acquired by Charles River Laboratories – Washington Business Journal
The firm helps gene therapy and vaccine companies develop and manufacture products for rare diseases. Image: Vigene Biosciences, led by CEO Zairen Sun, right,…
Read MoreAdaptive Phage Therapeutics Expands Board Following Series B Financing Led by Deerfield Management | Business Wire
GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced the appointment of…
Read MoreDC Region’s Life Sciences Sector Is on the Rise – Commercial Observer
Go pakh your cahr, Boston. Grab some granola, California. It’s D.C.’s moment in life sciences. For years, the Washington metropolitan area has been one…
Read MoreStartup Professionals Musings: 6 New Venture Realities To Target Your Funding Effort
Entrepreneurs who require funding for their startup have long counted on self-accredited high net worth individuals (“angels”) to fill their needs, after friends and…
Read MoreMy View: Angel investor extension means business for Arizona – Phoenix Business Journal
Since 2005, the Small Business Capital Investment Incentive has generated early-stage funding for more than 200 Arizona businesses, including my company, Qwick. I moved…
Read MoreMeacham: The DNA of entrepreneurship
Of the nearly 3 billion base pairs in the human genome, about 99% are the same in every human being — however, it is…
Read MoreOpen Positins at BD
BD is a leading global medical technology company that creates medical technology, devices and laboratory equipment for a variety of needs across the healthcare…
Read MoreCartesian Therapeutics President & Chief Executive Officer, Murat Kalayoglu, MD, PhD, Returns to BioTalk
Dr. Murat Kalayoglu, President and CEO at Cartesian Therapeutics, provides an update since his last visit on their cell and gene therapies, as well…
Read MoreNew rapid COVID testing options coming to Delta; Purchase and pack for smooth U.S. re-entry | Delta News Hub
Delta customers now have more ways to meet COVID-19 test requirements introduced by the U.S. Centers for Disease Control and many international governments during…
Read More